Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
2.210
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
2.180
-0.030 (-1.36%)
After-hours: Jun 27, 2025, 7:04 PM EDT
Savara Market Cap
Savara has a market cap or net worth of $465.63 million as of June 27, 2025. Its market cap has decreased by -19.19% in one year.
Market Cap
465.63M
Enterprise Value
322.02M
1-Year Change
-19.19%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $465.63M, an increase of 250.89%. That is a compound annual growth rate of 16.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 382.00M | -27.50% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.61B |
| Johnson & Johnson | 367.43B |
| AbbVie | 329.19B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 277.18B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 234.34B |
| AstraZeneca | 215.99B |